PHG or Siemens (and GE)

RBC’s analysts were given the task of finding the 30 “best money-making ideas in absolute terms using a risk-adjusted approach” from the 1500 or so stocks they cover worldwide. Koninklijke Philips Electronics was one of the lucky ones to rise to the top. They put it in the “Medical Equipment and Supplies” category. A more appropriate description would be “Consumer Electronics”. It’s traditional core business was, and is, making light bulbs as the original name, before the Royal prefix was added, attests to. It is to be hoped that this somewhat incorrect classification did not mislead the analyst. Philips is a great company but does it deserve such a recommendation? Here are a chart and some facts;

phg dec 28 2012phg 10 year facts 

The chart has all the hallmarks of a very large triangle, which could be either a 4th and we should get an explosive run up from the recent lows, or a B-triangle and we should dive into the ground. Alternatively, we are in a much smaller triangle that is in a 4th wave position but of a much smaller degree. We would have just finished wave c and still need to do d and e before going lower to, say the $5 area. On balance the whole pattern is bearish rather than bullish. There are not that many comparable companies but comparisons have been made with GE and SI. Both are more industrial, that is, in the heavy stuff like turbines etc. But just for the sake of the exercise here is the chart and info for Siemens.

si dec 28 2012SI dec 282012 10-year summary

The chart looks bearish overall but there is no triangle here. Relatively SI is higher up between the highs and lows than either PHG or, for that matter GE. But if you look at the 10-year summaries you will notice that SI has done much better, has grown more and has turned out much more consistent profits compared to extreme erratic profitability of PHG. You be the judge.

For completeness here is GE, it may or may not have completed the bear;

gedec 28 2012ge dec 28 10-year summary

GS Goldman Sachs, update

Then and now charts;

gs jul 2012 lgs dec 28 2012

We had this as a buy at $90 for a target of $135. It did not get there (yet) so we changed the outlook to include a triangle and now are changing it back again to the original a-b-c. Also, instead of contemplating a simple 5-wave sequence for wave C, we now prefer the notion that this may be a diagonal unfolding. This would allow for overlap that occurs at about $129 if you assume wave one to be larger than shown in this chart.

The alternate possibility that contradicts most other information, is that this stock is in a new bull market and is presently in wave 3 up. Not very likely. By the way, this pattern is very similar to that of Manulife and Morgan Stanley. Considering that this company is the global finishing school for central bankers and other powerful players we suspect that it will do better than MLF and /or MS.

Bayer

Then (a year ago) and now.

Bayer dec 18 2011Bayer AG dec 28 2012

Sometimes things do not work out. This is one of those times. Rather than succumb to bear pressures this stock decided to go in the opposite direction. It is a good reminder that the EW approach, or the practitioner, is not entirely infallible. At least we got the A-B-C part correctly, so in the event that one had played this one aggressively short, the damage would still be minimal (as measured from first blog!); and that assumes that no stops were used.  Now that we are here one must assume that there is either a distorted flat A-B-C on its own, or a triangle, equally ugly. The measurement for the triangle would be around $105. However the trend line is right here and the Mnt. Everest target is at an even $100. Our inclination is to get out or go short again even if demand for aspirins is about to explode.